CD8+ and CD4+ T cells are well established as the most prominent mediators of anti-cancer immunity [50], so our results suggest that PIEZO1 may also have a molecular role that reflects cancer aggressiveness and the suppression of anti-tumor immunity in HR-negative breast cancer. Here, CD4 is linked to neoplasm.